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THE BEGINNING
The Polish Cardiac Society (PCS) was founded in February 
1954, just a few years after the initiation of the European 
Society of Cardiology (ESC) on September 2, 1950. The first 
president of the PCS was between 1954 and 1961 Jerzy 
Jakubowski (Fig. 1A), although before hand a Working Group 
of Cardiology of the Polish Society of Internal Medicine existed 
with Mściwój Semerau-Siemianowski, president (Fig.  1B). 
Mściwój Semerau-Siemianowski together with Izabela 
Krzemińska-Ławkowiczowa pioneered cardiac catheterisation 
in Poland as early as 1948. Since 1954 Jerzy Jakubowski, was 
followed by 14 other eminent Polish cardiologists as presidents 
of the PCS (Table 1). 
Soon local chapters of the PCS were initiated in Gdańsk, 
Łódź, Poznań and Wrocław (1964), Katowice and Kraków 
(1965), Warsaw (1970), Lublin (1972), Białystok (1975), 
Szczecin (1975), Zabrze (1979, formally 1992), Toruń (1991), 
Bydgoszcz (1992). With increasing activities of the PCS, its 
membership grew from 550 in 1966 to 705 in 1970 to cur-
rently more than 6,000 members and 21 Working Groups.
THE PIONEERS
Polish cardiologists contributed early on to modern cardiology. 
For instance, Michael Mirowski (1924–1990) (Fig. 1C) made 
it to the National Inventors Hall of Fame for co-inventing 
with Morton Mower the automatic implantable-cardioverter 
defibrillator (ICD) in the 1960s after his mentor had died of 
a cardiac arrhythmia (patent number 4,202,340) [1]. Mirowski 
was born in Warsaw. During the 2nd World War, his father 
renamed him as Mieczysław Mirowski to protect him from 
the German Nazi regime. By 1944 he was an officer in a Po-
lish regiment, returned to Poland and registered as a medical 
student at the University of Gdańsk. Graduating in 1954, he 
seeked training in Israel before moving to the Sinai Hospital 
in Baltimore, Maryland, USA where he worked with Morton 
Mower and later Stephen Heilman’s artificial pacemaker 
company to develop the first ICD. On February 4, 1980, the 
first patient received an ICD at the Johns Hopkins Hospital, 
Baltimore, USA. 
Another milestone of Polish cardiology was the con-
struction of a prototype of an intravascular and intracardiac 
ultrasound by the surgeon and physicist Tadeusz Cieszyński 
in the 1960s [2]. His reports were published long before later 
technical developments allowed for its use in clinical practice 
[2]. During the 50th anniversary of the ESC, Tadeusz Cieszyński 
represented inventors from Poland at the poster exhibition.
On November 5, 1985, Zbigniew Religa (1938–2009) 
(Fig. 1D) performed the first successful heart transplantation 
at the Silesian Center for Heart Diseases in Zabrze. He was 
a prominent cardiac surgeon, scientist and politician. In 1964, 
he had completed his medical studies. After graduating and 
military service he joined the Wolski Hospital in Warsaw where 
he trained in surgery. In the 70s he held internships in the field 
of vascular surgery and cardiac surgery in the Mercy Hospital in 
New York and the Sinai Hospital in Detroit. Upon his return to 
Poland, he worked at the Institute of Cardiology in Warsaw to 
later become the director of the Department of Cardiac Surgery 
in Zabrze where he perfomed his seminal operation. 
TOWARDS THE POLISH ARTIFICIAL HEART 
Zbigniew Religa remained a pioneer of Polish cardiac surgery, 
performing for the first time in Poland heart and lung trans-
Table 1. Presidents of the Polish Cardiac Society
Names Years
J. Jakubowski 1954–1961
E. Żera 1962–1972 
Z. Askanas 1972–1973 
J. Kwoczyński 1973–1979 
W. Januszewicz 1980–1986 
K. Jasiński 1986–1989 
L. Ceremużyński 1989–1995 
M. Tendera 1995–1998 
W. Rużyłło 1998–2001
A. Cieśliński 2001–2004 
A. Torbicki 2004–2007 
A. Rynkiewicz 2007–2009 
W. Banasiak 2009–2011 
J. Stępińska 2011–2013
Z. Kalarus 2013–2015
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plant in 1986. Further, he initiated the Foundation of Cardiac 
Surgery Development chairing the Foundation Committee 
and the Artificial Heart Institute. The foundation’s mission is 
to support cardiac surgery in Poland through ongoing research 
in the field of biocybernetics, modern biotechnology and the 
development of novel valve and heart prosthesis. To that end 
he created the Artificial Heart Laboratory through a successful 
multidisciplinary collaboration and international cooperation 
with scientific institutions in the field of material technologies, 
nanotechnologies and bioengineering. These efforts led to the 
development of several cardiac devices, i.e. the extracorporeal 
ventricular assist device POLVAD-MEV with the in-hospital 
driving unit POLPDU-401, the pneumatic total heart pros-
thesis POLTAH, a prototype of implantable electro-hydraulic 
prosthesis for left ventricle assistance POLHIVAD, a model of 
implantable heart prosthesis, built of an elastic titanium nitride 
nanolayer on biocompatible polymer combined with the port-
able driving unit POLPDU-501. Notably, some of them were 
successfully implemented into clinical practice, others used 
for experimental research. At the end of his scientific career, 
Zbigniew Religa became a Minister of Health of Poland.
On December 13th 2013, the “Polish Artificial Heart”, 
a project supported by the Ministry of Health and initiated 
by Zbigniew Religa, had been presented. The “Religa Heart 
EXT” passed the first phase of experimental studies at the 
Warsaw Institute of Cardiology. The Ethics Committee appro-
ved the launch of the second phase. The Polish artificial heart 
remains a ray of hope particularly for patients who cannot 
be transplanted. 
INTERVENTIONAL CARDIOLOGY
Witold Rużyłło is the father of interventional cardiology in 
Poland. He performed the first percutaneous coronary in-
tervention (PCI) in 1981, four years after Andreas Grüntzig’s 
seminal first coronary angioplasty in Zürich, Switzerland 
[3]. During his career he connected Polish cardiology with 
Europe by serving for several terms on the Board of both the 
PCS and ESC. 
Through his efforts evidence-based practice in PCI was 
implemented rapidly in Poland. The number of catheterisa-
tion laboratories increased dramatically, mostly over the last 
decade, to currently 216,000 coronary angiographies and 
119,000 PCIs annually. Notably, of 153 centres performing 
PCI, 143 currently provide a 24/7 service for primary PCI. 
Further, 141 cardiology centres perform electrophysiological 
procedures for arrhythmias. 
THE POLISH SOCIETY OF CARDIOLOGY TODAY
From its initiation the PCS had a great influence on cardiology 
practice in the country. Currently, the PCS is among 6 largest 
national societies of the ESC. One of the key activities of the 
PCS in Poland was “PCS on the road” whereby in several ci-
ties annual international conferences were hosted with over 
4,000 delegates each year. Due to the growth of its congress, 
only 2 Polish centers, i.e. Poznań and Wrocław, are at the 
moment able to accommodate this event. The annual meet-
ings of PCS had a huge impact on the implementation of 
evidence-based medicine, structured training along European 
recommendations and in turn on improved patients care. 
One of the features developed during the PCS presidency 
of Janina Stępińska was a Multimedia Educational Platform 
available on the website of PCS. Over the last 2 years, the 
platform was used by more than 1,500 physicians who par-
ticipated in e-learning educational courses comprising over 
30 comprehensive lectures by over 100 Polish experts. The 
courses of the platform are obligatory for fellows in cardio-
logy training.
Most recently, the PCS focused on primary prevention, 
intensive cardiac care using also e-learning platforms. Indeed, 
as Poland is experiencing cardiovascular diseases on an epide-
Figure 1. Pioneers of Polish cardiology: Jerzy Jakubowski, the first president of the Polish Cardiac Society between 1954–1961 (A);  
Mściwój Semerau-Siemianowski, initiatior of Working Group of Cardiology of the Polish Society of Internal Medicine in 1950 (B); 
Michael Mirowski (1924–1990) (C) co-inventor with Morton Mower of the automatic implantable cardioverter-defibrillator; 
Zbigniew Religa (1938–2009) (D), who performed the first successful heart transplantation in Poland in 1985
A CB D
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mic level, the POLSCREEN program was established to assess 
cholesterol levels in 1 million outpatients and to implemental 
educational programs on secondary prevention. Finally, the 
POLKARD 2003–2005 program with its scientific advisory 
board led by Grzegorz Opolski had been started as a response 
of the Ministry of Health to financially support of modern 
treatment strategies of cardiovascular diseases.
POLISH CARDIOLOGISTS AND  
THE EUROPEAN SOCIETY OF CARDIOLOGY
Despite of their political isolation within Eastern Europe after 
the war, Polish cardiologists could overcome such barriers 
through international contacts in Western Europe or United 
States. Nowadays cardiologists from Poland are actively in-
volved in major national and international educational and 
research initiatives, including ESC Task Forces and the ESC 
Guidelines Committee. Some of them have played a key role 
within the ESC, notably Michał Tendera who has served as 
a board member in several positions and finally as President 
in 2004–2006. Further, Adam Torbicki, who presided the 
PCS from 2004–2007, served as Vice-President of the ESC in 
2010–2012. Several Polish cardiologists are highly recognised 
internationally and very well cited (Table 2).
THE “EUROPEAN HEART JOURNAL” (EHJ)
The “European Heart Journal” (EHJ) was launched in 1980 and 
has grown impressively with the ever higher impact factor peak-
ing at 14.1 recently. As a consequence of increased submissions, 
the acceptance rate has dropped to 11%. In 2009, the new 
editorial team of the EHJ established the ESC journal family, 
currently involving 9 subspecialty journals (Fig. 2). In order to 
work together efficiently, the editors of all specialty journals were 
invited to become senior consulting editors of the EHJ and a novel 
manuscript transfer system was established. 
POLISH CARDIOLOGY AND THE EHJ
Over the last 5 years, 246 papers were submitted by Polish 
cardiologists to the EHJ with an acceptance rate of 14%. Of 
note, the best cited papers submitted to EHJ were authored by 
Michał Tendera and Adam Torbicki. The original research arti-
cle “Intracoronary infusion of bone marrow-derived selected 
Table 2. Most citated cardiologists
Names H-index*
Ponikowski Piotr 59
Budaj Andrzej 55
Tendera Michał 51
Torbicki Adam 43
Rużyłło Witold 41
Dudek Dariusz 39
Narkiewicz Krzysztof 37
*Based on SCOPUS Database, 13.12.2013
Figure 2. The ESC journal family with their according impact factors and editors
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Table 3. Ten best cited papers of “European Heart Journal” — Poland
Authors Title Cites* Cites** Year
Tendera M, Wojakowski W, Ruzyllo W, 
Chojnowska L, Kepka C, Tracz W, 
Musialek P, Piwowarska W, Nessler J, 
Buszman P, Grajek S, Breborowicz P, 
Majka M, Ratajczak MZ [4]
Intracoronary infusion of bone marrow-derived selected 
CD34(+)CXCR(+) cells and non-selected mononuclear cells in 
patients with acute STEMI and reduced left ventricular ejection 
fraction: results of randomised, multicentre Myocardial Rege-
neration by Intracoronary Infusion of Selected Population of 
Stem Cells in Acute Myocardial Infarction (REGENT) trial
148 201 2009
Torbicki A, Perrier A, Konstantinides S, 
Agnelli G, Galie N, Pruszczyk P, Bengel F, 
Brady AJ, Ferreira D, Janssens U, Klepetko W, 
Mayer E, Remy-Jardin M, Bassand JP [5]
Guidelines on the diagnosis and management of acute pulmo-
nary embolism: the Task Force for the diagnosis and manage-
ment of acute pulmonary embolism of the European Society of 
Cardiology (ESC)
580 903 2008
Ronco C, McCullough P, Anker SD, Anand I, 
Aspromonte N, Bagshaw SM, Bellomo R, 
Berl T, Bobek I, Cruz DN, Daliento L,  
Da venport A, Haapio M, Hillege H, 
House AA, Katz N, Maisel A, Mankad S, 
Zanco P, Mebazaa A, Palazzuoli A, Ronco F, 
Shaw A, Sheinfeld G, Soni S, Vescovo G,  
Zamperetti N, Ponikowski P [6]
Cardio-renal syndromes: report from the consensus conference 
of the Acute Dialysis Quality Initiative
112 175 2010
Tendera M, Aboyans V, Bartelink ML, 
Baumgartner I, Clement D, Collet JP,  
Cremonesi A, De Carlo M, Erbel R, 
Fowkes FG, Heras M, Kownator S, Minar E, 
Ostergren J, Poldermans D, Riambau V,  
Roffi M, Rother J, Sievert H,  
van Sambeek M, Zeller T [7]
ESC Guidelines on the diagnosis and treatment of peripheral 
artery diseases: document covering atherosclerotic disease of 
extracranial carotid and vertebral, mesenteric, renal, upper and 
lower extremity arteries: the Task Force on the diagnosis and 
treatment of peripheral artery diseases of the European Society 
of Cardiology (ESC)
93 163 2011
De Luca G, Dudek D, Sardella G,  
Marino P, Chevalier B, Zijlstra F [8]
Adjunctive manual thrombectomy improves myocardial perfu-
sion and mortality in patients undergoing primary percutaneous 
coronary intervention for ST-elevation myocardial infarction: 
a metaanalysis of randomized trials
86 136 2008
Tardif JC, Ponikowski P, Kahan T [9] Efficacy of the i(f) current inhibitor ivabradine in patients with 
chronic stable angina receiving beta-blocker therapy: a 4-month, 
randomized, placebo-controlled trial
85 129 2009
Kuliczkowski W, Witkowski A, Polonski L, 
Watala C, Filipiak K, Budaj A, Golanski J, 
Sitkiewicz D, Pregowski J, Gorski J, 
Zembala M, Opolski G, Huber K,  
Arnesen H, Kristensen SD,  
De Caterina R [10]
Interindividual variability in the response to oral antiplatelet 
drugs: a position paper of the Working Group on antiplatelet 
drugs resistance appointment by the Section of Cardiovascular 
Interventions of the Polish Cardiac Society, endorsed by the 
Working Group on thrombosis of the European Society of 
Cardiology
84 105 2009
Burzotta F, De Vita M, Gu YL, Isshiki T, 
Lefevre T, Kaltoft A, Dudek D, Sardella G, 
Orrego PS, Antoniucci D, De Luca L, 
Biondi-Zoccai GG, Crea F, Zijlstra F [11]
Clinical impact of thrombectomy in acute ST-elevation myo-
cardial infarction: an individual patient-data pooled analysis of 
11 trials
82 123 2009
Oldgren J, Budaj A, Granger CB, Khder Y, 
Roberts J, Siegbahn A, Tijssen JG,  
Van de Werf F, Wallentin L [12]
Dabigatran vs. placebo in patients with acute coronary syn-
dromes on dual antiplatelet therapy: a randomized, dou-
ble-blind, phase II trial
69 145 2011
Jankowska EA, Rozentryt P, Witkowska A, 
Nowak J, Hartmann O, Ponikowska B, 
Borodulin-Nadzieja L, Banasiak W,  
Polonski L, Filippatos G, McMurray JJ, 
Anker SD, Ponikowski P [13]
Iron deficiency: an ominous sign in patients with systolic chronic 
heart failure
54 77 2010
Surenames of all Polish cardiologists, co-authors of 10 most cited papers in “European Heart Journal” with any Polish affiliations, have been bolded. 
*EHJ Office; **Based on SCOPUS Database, 08.01.2013
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CD34(+)CXCR4(+) cells and non-selected mononuclear cells 
in patients with acute STEMI and reduced left ventricular ejec-
tion fraction: results of randomised, multicenter Myocardial 
Regeneration by Intracoronary Infusion of Selected Population 
of Stem Cells in Acute Myocardial Infarction (REGENT) trial”, 
where Michał Tendera was the first author was cited 148 times 
[4]. The “Guidelines on the diagnosis and management of 
acute pulmonary embolism: the Task Force for the diagnosis 
and management of acute pulmonary embolism of the Euro-
pean Society of Cardiology (ESC)”, were Adam Torbicki was an 
author was cited 580 times [5]. Further remarkable papers by 
Polish cardiologists published in the EHJ are listed in Table 3.
ANNUAL CONGRESS OF THE  
EUROPEAN SOCIETY OF CARDIOLOGY
The annual congress of ESC has become the largest interna-
tional forum worldwide with one third of attendees coming 
from non-ESC countries. Since the first congress, the number 
of participants has increased impressively and reached its 
maximum in Paris in 2012 with 32,000 attendees. The larg-
est numbers of delegates came from Germany, France Italy, 
Japan and USA. The number of Polish delegates averaged 
around 500. From 2008 to 2013, Polish cardiologists sub-
mitted a total of 1,589 abstracts with an acceptance rate of 
over 30%. Indeed, over 500 abstracts were accepted for oral 
presentations or as a poster.
Interestingly, more than 80 Polish cardiologists and car-
diac surgeons travelled by a ship with the “Dar Młodzieży” 
to the ESC Congress in Amsterdam (Fig. 3) to express their 
gratitude to the Netherlands for conducting more than 
400 life-saving operations on Polish children with congenital 
heart disease in 1983–1990. Through this initiative, Polish 
cardiologists, cardiac surgeons, anesthesiologists and nurses 
were trained. As a consequence, many centres in Poland are 
now able to manage patients with congenital heart disease, 
including the prenatal care.
THE “POLISH HEART JOURNAL” (PHJ)
The “Polish Heart Journal” (PHJ) is the official journal of the 
PCS. The first issue of the PHJ was published in 1957 under the 
editorship of Jerzy Jakubowski. Of note, within last 5 decades 
the quality of the journal grew constantly to become an inter-
esting and valuable forum of key opinion leaders. Currently, 
the journal publishes original research, reviews, editorials 
and clinical vignettes available in English being referenced in 
Medline with a current impact factor of 0.536. 
“CLUB 30” — A FORUM  
FOR YOUNG CARDIOLOGISTS
Long before the ESC established the “Cardiologists of tomor-
row”, Leszek Ceremużyński in 1994 initiated the “Club 30”, 
as an official unit within the PCS with the intent to bring to-
gether the most promising young Polish cardiologists who are 
internationally recognised despite their young age. Notably, 
members of “Club 30” are recipients of international awards, 
including ESC Grants and Fellowships. The Club’s activity 
includes spring meetings, symposia during PCS congress and 
even sessions during the annual ESC congress. 
THE FUTURE
The challenges that PCS face over the next half-century are 
no different to any other European society. During 50th An-
niversary Congress in 2004, Adam Torbicki, the then President 
Elect of the PCS, argued that in clinical cardiology efforts 
should focus on implementing guidelines, on continuing 
medical education and in the accreditation of cardiovascular 
laboratories. 
Conflict of interest: none declared
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